Palmitic acid enhances cholesterol gallstone incidence in Sasco hamsters fed cholesterol enriched diets.
In an established hamster model of cholesterol cholelithiasis, a semipurified lithogenic diet containing 4% butterfat and 0.3% cholesterol leads to the production of cholesterol gallstones in only 50-60% of animals after a 6-wk feeding period. The purpose of this study was to investigate whether gallstone incidence could be increased while feeding a nutritionally adequate diet of moderate cholesterol content. The semipurified lithogenic diet was modified as follows: (i) substitution of 1.2% palmitic acid for 4% butterfat, and (ii) varying the amount of dietary cholesterol from 0.0 to 0.3% with either butterfat or palmitic acid as the lipid component of the diet. Substitution of palmitic acid for butterfat produced a significantly higher incidence of cholesterol gallstones (94% vs. 53%). Palmitic acid also raised the incidence of gallstones when added to the 0.1% and 0.2% cholesterol diets as compared to butterfat: 0% vs. 44% and 50% vs. 81%, respectively. Gallstone incidence increased from 0% to nearly 100% when the cholesterol content of the palmitic acid diets was raised from 0.0% to 0.3%, indicating a dose response effect with respect to dietary cholesterol. Hamsters fed cholesterol-free diets did not form gallstones. Increased dietary cholesterol led to increased liver weight associated with a significant increase in liver cholesterol concentration. However, the palmitic acid groups had significantly lower liver cholesterol values than the corresponding butterfat groups. Serum and biliary cholesterol concentrations increased with increasing dietary cholesterol intake, but there were no differences between the butterfat and palmitic acid groups.(ABSTRACT TRUNCATED AT 250 WORDS)
Ayyad
N
N
Department of Surgery, Beth Israel Medical Center, New York, New York 10003.
Cohen
B I
BI
Mosbach
E H
EH
Miki
S
S
D000818:Animals; D001646:Bile / Q000737:chemistry; D001647:Bile Acids and Salts / Q000737:chemistry; D001835:Body Weight; D002769:Cholelithiasis / Q000139:chemically induced*; D002791:Cholesterol, Dietary / Q000494:pharmacology*; D006224:Cricetinae; D004041:Dietary Fats / Q000494:pharmacology*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005704:Gallbladder / Q000473:pathology*; D008055:Lipids / Q000737:chemistry; D008099:Liver / Q000737:chemistry; D008297:Male; D008647:Mesocricetus; D009929:Organ Size; D019308:Palmitic Acid; D010169:Palmitic Acids / Q000494:pharmacology*
D001647:Bile Acids and Salts; D002791:Cholesterol, Dietary; D004041:Dietary Fats; D008055:Lipids; D010169:Palmitic Acids; D019308:Palmitic Acid